Samuel D Colella - Net Worth and Insider Trading
Samuel D Colella Net Worth
The estimated net worth of Samuel D Colella is at least $39 Million dollars as of 2024-11-10. Samuel D Colella is the Director, 10% Owner of Flexion Therapeutics Inc and owns about 3,996,929 shares of Flexion Therapeutics Inc (FLXN) stock worth over $36 Million. Samuel D Colella is the Director of Genomic Health Inc and owns about 36,437 shares of Genomic Health Inc (GHDX) stock worth over $2 Million. Samuel D Colella is also the Director of Standard BioTools Inc and owns about 239,268 shares of Standard BioTools Inc (LAB) stock worth over $514,426. Details can be seen in Samuel D Colella's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Samuel D Colella has not made any transactions after 2020-03-11 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Samuel D Colella
Samuel D Colella Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Samuel D Colella owns 12 companies in total, including Flexion Therapeutics Inc (FLXN) , Standard BioTools Inc (LAB) , and Glaukos Corp (GKOS) among others .
Click here to see the complete history of Samuel D Colella’s form 4 insider trades.
Insider Ownership Summary of Samuel D Colella
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
FLXN | Flexion Therapeutics Inc | 2020-06-10 | director & 10 percent owner |
LAB | Standard BioTools Inc | 2020-03-11 | director |
GKOS | Glaukos Corp | 2015-06-24 | 10 percent owner |
2016-05-23 | 10 percent owner | ||
2014-09-09 | 10 percent owner | ||
2014-11-18 | 10 percent owner | ||
2013-10-29 | director & 10 percent owner | ||
2012-06-06 | other: Former Director | ||
2007-05-31 | director | ||
2007-05-14 | 10 percent owner | ||
2006-05-09 | 10 percent owner | ||
2014-11-18 | 10 percent owner |
Samuel D Colella Latest Holdings Summary
Samuel D Colella currently owns a total of 3 stocks. Among these stocks, Samuel D Colella owns 3,996,929 shares of Flexion Therapeutics Inc (FLXN) as of August 8, 2019, with a value of $36 Million and a weighting of 92.81%. Samuel D Colella owns 36,437 shares of Genomic Health Inc (GHDX) as of November 20, 2012, with a value of $2 Million and a weighting of 5.89%. Samuel D Colella also owns 239,268 shares of Standard BioTools Inc (LAB) as of March 11, 2020, with a value of $514,426 and a weighting of 1.31%.
Latest Holdings of Samuel D Colella
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
FLXN | Flexion Therapeutics Inc | 2019-08-08 | 3,996,929 | 9.12 | 36,451,992 |
GHDX | Genomic Health Inc | 2012-11-20 | 36,437 | 63.44 | 2,311,563 |
LAB | Standard BioTools Inc | 2020-03-11 | 239,268 | 2.15 | 514,426 |
Holding Weightings of Samuel D Colella
Samuel D Colella Form 4 Trading Tracker
According to the SEC Form 4 filings, Samuel D Colella has made a total of 0 transactions in Flexion Therapeutics Inc (FLXN) over the past 5 years. The most-recent trade in Flexion Therapeutics Inc is the acquisition of 2,000 shares on August 8, 2019, which cost Samuel D Colella around $21,480.
According to the SEC Form 4 filings, Samuel D Colella has made a total of 0 transactions in Genomic Health Inc (GHDX) over the past 5 years. The most-recent trade in Genomic Health Inc is the sale of 30,616 shares on November 20, 2012, which brought Samuel D Colella around $823,264.
According to the SEC Form 4 filings, Samuel D Colella has made a total of 1 transactions in Standard BioTools Inc (LAB) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Standard BioTools Inc is the acquisition of 20,000 shares on March 11, 2020, which cost Samuel D Colella around $54,200.
Insider Trading History of Samuel D Colella
- 1
Samuel D Colella Trading Performance
GuruFocus tracks the stock performance after each of Samuel D Colella's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Samuel D Colella is -0.07%. GuruFocus also compares Samuel D Colella's trading performance to market benchmark return within the same time period. The performance of stocks bought by Samuel D Colella within 3 months outperforms 8 times out of 15 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Samuel D Colella's insider trading performs compared to the benchmark.
Performance of Samuel D Colella
Samuel D Colella Ownership Network
Ownership Network List of Samuel D Colella
Ownership Network Relation of Samuel D Colella
Samuel D Colella Owned Company Details
What does Flexion Therapeutics Inc do?
Who are the key executives at Flexion Therapeutics Inc?
Samuel D Colella is the director & 10 percent owner of Flexion Therapeutics Inc. Other key executives at Flexion Therapeutics Inc include Chief Regulatory Officer Kerry Wentworth , Chief Strategy Officer Christina Willwerth , and General Counsel Mark S. Levine .
Flexion Therapeutics Inc (FLXN) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Flexion Therapeutics Inc (FLXN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Flexion Therapeutics Inc (FLXN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Flexion Therapeutics Inc (FLXN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Flexion Therapeutics Inc Insider Transactions
Samuel D Colella Mailing Address
Above is the net worth, insider trading, and ownership report for Samuel D Colella. You might contact Samuel D Colella via mailing address: One Sansome Street, Suite 3630, San Francisco Ca 94104.